Latest Articles

Publication Date
Endometriosis pill: Everything you need to know about the groundbreaking NHS treatment - MSN

Endometriosis pill: Everything you need to know about the groundbreaking NHS treatment MSN

Published: Sept. 29, 2025, 10:50 a.m.
United States Endometriosis Treatment Market Report 2025: Pain - openPR.com

United States Endometriosis Treatment Market Report 2025: Pain openPR.com

Published: Sept. 29, 2025, 10:32 a.m.
Effectiveness and Safety of Postoperative Medical Treatments Following Fertility-Preserving Surgery for Endometriosis: A Network Meta-Analysis.

Endometriosis (EMs) is a common gynaecological condition with high recurrence rates after fertility-preserving laparoscopic surgery, and optimal postoperative medical treatment remains unclear.

Published: Sept. 29, 2025, midnight
Erythema ab igne-A Potential Cutaneous Marker of Chronic Heat Use in Patients with Endometriosis: A Narrative Literature Review and a Case Report.

Erythema ab igne (EAI), also known as "hot water bottle rash" or "toasted skin syndrome", is a benign cutaneous condition caused by chronic exposure to low-level infrared heat. It typically …

Published: Sept. 29, 2025, midnight
Vancouver Island women's cancer treatment could get an AI boost - Ladysmith Chemainus Chronicle

Vancouver Island women's cancer treatment could get an AI boost Ladysmith Chemainus Chronicle

Published: Sept. 28, 2025, 8:02 p.m.
Vancouver Island women's cancer treatment could get an AI boost - Vancouver Island Free Daily

Vancouver Island women's cancer treatment could get an AI boost Vancouver Island Free Daily

Published: Sept. 28, 2025, 2 p.m.
Clinicopathological Characteristics and Oncologic Outcomes of Endometrioid Ovarian Carcinoma: A Retrospective Study from a Tertiary Cancer Centre.

Background/Objectives: To evaluate the clinicopathological features, treatment, and survival outcomes and to identify independent prognosticators for recurrence and mortality in patients with endometrioid ovarian cancer. Methods: The medical records of …

Published: Sept. 28, 2025, midnight
Lab-Grown Organoids Advance Treatments for Women’s Reproductive Health - WebProNews

Lab-Grown Organoids Advance Treatments for Women’s Reproductive Health WebProNews

Published: Sept. 27, 2025, 4:55 p.m.
Dual Targeting of Orphan Nuclear Receptors NR4A1 and NR4A2 for Non-Hormonal Endometriosis Therapy.

Previous studies show that orphan nuclear receptor 4A1 (NR4A1) regulated endometriotic cell growth, survival, estrogen receptor β (ERβ), mTOR signaling and fibrosis. NR4A2 is also expressed in epithelial and stromal …

Published: Sept. 26, 2025, midnight
Endometriosis-associated infertility alters the microRNA signatures of cumulus cells with a particularly pronounced effect in oocytes that failed fertilization.

Endometriosis (E) is multifactorial disease affecting around 10% of women worldwide. The association between E and infertility is clinically well recognized. For E patients to achieve a successful pregnancy, assisted …

Published: Sept. 26, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!